BR0015477A - Soluções contendo epinastina - Google Patents

Soluções contendo epinastina

Info

Publication number
BR0015477A
BR0015477A BR0015477-6A BR0015477A BR0015477A BR 0015477 A BR0015477 A BR 0015477A BR 0015477 A BR0015477 A BR 0015477A BR 0015477 A BR0015477 A BR 0015477A
Authority
BR
Brazil
Prior art keywords
solutions containing
containing epinastine
optionally
epinastine
racemate
Prior art date
Application number
BR0015477-6A
Other languages
English (en)
Inventor
Volker Trach
Gerold Duchler
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0015477(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0015477A publication Critical patent/BR0015477A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

"SOLUçõES CONTENDO EPINASTINA". A invenção refere-se a soluções aquosas topicamente aplicáveis contendo epinastina, opcionalmente na forma de seu racemato, seus enanciómeros, assim como opcionalmente na forma de seus sais ácidos de adição farmacologicamente inofensivos.
BR0015477-6A 1999-11-12 2000-10-14 Soluções contendo epinastina BR0015477A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (1)

Publication Number Publication Date
BR0015477A true BR0015477A (pt) 2002-06-25

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015477-6A BR0015477A (pt) 1999-11-12 2000-10-14 Soluções contendo epinastina

Country Status (40)

Country Link
US (6) US20030050303A1 (pt)
EP (1) EP1231920B1 (pt)
JP (1) JP2003514021A (pt)
KR (1) KR100758842B1 (pt)
CN (1) CN1292752C (pt)
AR (1) AR026424A1 (pt)
AT (1) ATE353218T1 (pt)
AU (2) AU784017B2 (pt)
BG (1) BG65775B1 (pt)
BR (1) BR0015477A (pt)
CA (1) CA2391076C (pt)
CO (1) CO5251448A1 (pt)
CY (1) CY1106375T1 (pt)
CZ (1) CZ302483B6 (pt)
DE (2) DE19954516A1 (pt)
DK (1) DK1231920T3 (pt)
EA (1) EA006937B1 (pt)
EE (1) EE05395B1 (pt)
ES (1) ES2281359T3 (pt)
HK (1) HK1052303B (pt)
HR (1) HRP20020404B1 (pt)
HU (1) HU229502B1 (pt)
IL (2) IL149501A0 (pt)
ME (1) MEP36708A (pt)
MX (1) MXPA02004556A (pt)
MY (1) MY130441A (pt)
NO (1) NO329417B1 (pt)
NZ (1) NZ519425A (pt)
PE (1) PE20010826A1 (pt)
PL (1) PL198879B1 (pt)
PT (1) PT1231920E (pt)
RS (1) RS50173B (pt)
SA (1) SA01210658B1 (pt)
SI (1) SI1231920T1 (pt)
SK (1) SK287343B6 (pt)
TR (1) TR200201270T2 (pt)
TW (1) TWI225401B (pt)
UA (1) UA74563C2 (pt)
WO (1) WO2001035962A1 (pt)
ZA (1) ZA200203683B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
CN101217948A (zh) * 2005-07-08 2008-07-09 千寿制药株式会社 包含依匹那丁的透皮吸收眼科制剂
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
BR112015014367B1 (pt) * 2012-12-19 2022-11-22 Novartis Ag Composição inibidora de lfa-1, método para estabilizar a dita composição e uso da mesma para tratar uma doença ocular
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
WO2018203424A1 (ja) * 2017-05-01 2018-11-08 参天製薬株式会社 点眼剤
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja) 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US215396A (en) * 1879-05-13 Improvement in loom-temples
US228359A (en) * 1880-06-01 jones
US181478A (en) * 1876-08-22 Improvement in water-wheels
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US8632A (en) * 1852-01-06 George hess
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
UA62917C2 (en) * 1995-06-27 2004-01-15 Berinher Inhelheim Kg Medicinal composition for generating propellant-free aerosols
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
US6201011B1 (en) * 1996-08-30 2001-03-13 Kyoto Pharmaceutical Industries, Ltd. Therapeutic agent for allergic dermatitis
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
MXPA02005007A (es) * 1999-11-18 2004-08-12 Alcon Inc Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
AU2002305780A1 (en) * 2001-05-29 2002-12-09 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
PL198879B1 (pl) 2008-07-31
NZ519425A (en) 2004-04-30
HUP0203773A3 (en) 2005-01-28
ATE353218T1 (de) 2007-02-15
EA200200492A1 (ru) 2002-10-31
HRP20020404B1 (hr) 2007-08-31
PE20010826A1 (es) 2001-08-20
UA74563C2 (uk) 2006-01-16
EE200200246A (et) 2003-06-16
KR100758842B1 (ko) 2007-09-19
RS50173B (sr) 2009-05-06
EP1231920B1 (de) 2007-02-07
BG65775B1 (bg) 2009-11-30
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
US20070197503A1 (en) 2007-08-23
CO5251448A1 (es) 2003-02-28
TR200201270T2 (tr) 2002-12-23
SK287343B6 (sk) 2010-07-07
EE05395B1 (et) 2011-04-15
US20080009476A1 (en) 2008-01-10
BG106681A (en) 2002-12-29
JP2003514021A (ja) 2003-04-15
IL149501A0 (en) 2002-11-10
US20030050303A1 (en) 2003-03-13
PL364028A1 (en) 2004-11-29
CZ20021956A3 (cs) 2002-08-14
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
DE50014041D1 (de) 2007-03-22
ES2281359T3 (es) 2007-10-01
US20070185082A1 (en) 2007-08-09
EA006937B1 (ru) 2006-06-30
ZA200203683B (en) 2003-09-03
MY130441A (en) 2007-06-29
NO329417B1 (no) 2010-10-18
DK1231920T3 (da) 2007-04-10
CY1106375T1 (el) 2011-10-12
YU33602A (sh) 2005-03-15
DE19954516A1 (de) 2001-05-17
HK1052303B (zh) 2007-04-13
MXPA02004556A (es) 2004-09-10
KR20020050273A (ko) 2002-06-26
SK8302002A3 (en) 2002-09-10
CA2391076A1 (en) 2001-05-25
AR026424A1 (es) 2003-02-12
US7429602B2 (en) 2008-09-30
AU784017B2 (en) 2006-01-12
AU2006201541A1 (en) 2006-05-11
AU1138101A (en) 2001-05-30
HK1052303A1 (en) 2003-09-11
IL149501A (en) 2012-04-30
HU229502B1 (en) 2014-01-28
SI1231920T1 (sl) 2007-06-30
CN1390129A (zh) 2003-01-08
NO20022201L (no) 2002-05-08
US20050288274A1 (en) 2005-12-29
MEP36708A (en) 2011-02-10
PT1231920E (pt) 2007-03-30
WO2001035962A1 (de) 2001-05-25
CZ302483B6 (cs) 2011-06-08
CA2391076C (en) 2008-06-17
CN1292752C (zh) 2007-01-03
SA01210658B1 (ar) 2006-11-05
US20090239842A1 (en) 2009-09-24
EP1231920A1 (de) 2002-08-21

Similar Documents

Publication Publication Date Title
BR0015477A (pt) Soluções contendo epinastina
SV2002000356A (es) Nuevos derivados de piperazina ref. pc10770aixn/bb
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
PA8474201A1 (es) Jarabe antihistaminico estabilizado
DE60130758D1 (de) Zeolith ssz-53
BR0113890A (pt) Derivados de ácido hexenóico e 2-amino-2-alquil-4 hexenóico úteis como inibidores de sintase de óxido nìtrico
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
BR9916111A (pt) Derivados de fenilglicina
YU2003A (sh) Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
WO2003082855A1 (en) Anti-inflammatory agent
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
DOP2001000268A (es) Derivados puente de piperazina
BRPI0406704A (pt) Antagonistas de 5ht~7~ e agonistas inversos
BR0108501A (pt) Compostos de n-hidróxiformamidas substituìdos por piperidina e piperazina como agentes inibidores de metaloproteinase
BR0013651A (pt) Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados
BR0013502A (pt) Inibidores da integrina alfav beta3
BRPI0403909A (pt) Solução aquosa de tensoativos anfotéricos altamente concentrada
AR027349A1 (es) Derivados de amidas heterociclicas
BR0214615A (pt) Composto hexacìclico
BR0107483A (pt) Processo para a preparação de um composto
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
UY26432A1 (es) Soluciones que contienen epinastina
ES2173280T3 (es) Composiciones pulverulentas y solubles en agua y sus aplicaciones.s
BR0008442A (pt) Formulação efervescente farmacêutica, contendo metamizol

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 10 ( VIII ) DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]